TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OPRX

OPTIMIZERx Corp

Healthcare · Health Information Services

7.90$ +3.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

OPTIMIZERx Corp (OPRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 164 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OPRX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
11 11 11 10 9.8 9.8 9.3 19 20 25 25 50 49 57 56 56 55 60 128 132 135 141 138 147 136 135 132 121 124 183 176 173 165 171 168 169 170 177 167 164
10 10 9.6 8.5 8.0 8.8 8.3 18 19 16 15 39 38 27 27 28 27 33 101 105 108 115 113 110 99 99 96 85 87 54 48 46 47 54 52 54 56 65 56 54
7.6 7.0 6.7 5.8 5.0 5.1 4.3 12 14 8.9 10 31 30 19 15 14 12 11 82 84 85 85 89 87 41 18 16 9.8 9.9 14 15 15 16 13 17 17 20 23 20 24
7.6 7.0 6.7 5.8 5.0 5.1 4.3 12 14 8.9 10 31 30 19 15 14 12 11 82 84 85 85 89 87 79 74 74 63 64 – 15 15 16 13 17 17 20 23 20 24
2.3 3.1 2.8 2.4 2.7 3.4 3.8 5.5 5.2 6.5 4.9 7.4 7.2 7.4 9.1 11 13 18 15 18 21 25 19 19 18 22 18 18 21 36 31 26 26 38 33 34 34 39 33 27
0.0 – 0.0 – – 0.0 – 0.0 – – 0.0 – – – 0.0 0.0 0.0 – – 0.0 – – 0.0 0.0 – 1.8 0.0 0.0 – – 0.0 – -4.4 – – – – – – –
0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.8 0.8 0.7 0.7 0.7 0.7 0.2 0.1 0.1 0.5 0.1 0.5 0.1 0.1 0.4 0.1 0.1 0.1 – – – – – – – – – – – –
1.2 1.1 1.1 1.8 1.7 0.8 0.8 0.8 0.7 3.7 3.7 3.7 3.7 15 15 15 15 15 15 15 15 15 15 23 23 23 23 23 23 78 78 78 71 71 71 71 71 71 71 71
1.2 1.1 1.1 1.8 1.7 0.8 0.8 0.8 0.7 5.3 5.1 6.4 6.1 14 13 13 13 12 12 11 11 11 11 14 13 13 13 13 12 49 48 47 46 46 45 43 42 41 40 32
3.2 3.7 3.9 4.0 3.8 3.5 2.4 2.8 2.6 6.6 5.8 7.7 7.4 12 13 13 8.5 10 5.7 6.9 7.8 9.6 7.1 6.6 6.3 8.5 7.7 5.5 7.8 57 54 52 51 54 51 50 48 49 38 33
3.2 3.7 3.9 4.0 3.8 3.5 2.4 2.8 2.6 4.2 3.9 5.7 5.4 6.1 9.5 12 8.1 10 5.4 6.7 7.6 9.4 6.9 6.4 6.1 8.4 7.6 5.5 7.7 18 17 15 15 19 18 21 18 21 10 9.7
– 2.5 1.9 1.9 1.9 1.2 0.9 – – – 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 – 3.7 3.5 2.2 2.2 3.4 3.5 3.5 4.4 2.2 1.5
0.2 0.4 0.5 0.9 0.7 0.5 0.1 0.2 0.2 0.4 0.6 0.9 1.1 0.5 0.5 0.5 0.5 0.6 0.5 0.8 0.8 5.0 3.8 3.7 3.7 1.5 1.3 0.8 0.7 2.2 1.7 3.0 2.8 2.2 3.4 2.0 2.0 1.6 3.1 1.3
– – – – – – – – – – 0.5 – – – – – – – – – – – – – – – – – – 34 32 32 33 31 29 25 25 21 21 18
8.0 7.8 7.1 6.5 6.1 6.2 6.8 16 17 18 19 42 41 45 44 44 47 50 122 125 127 131 131 141 130 126 124 116 116 127 123 121 114 117 116 119 122 128 130 131
-28 -28 -29 -30 -30 -30 -31 -30 -30 -30 -30 -30 -31 -33 -36 -37 -37 -36 -36 -36 -36 -35 -39 -43 -46 -47 -53 -57 -60 -64 -71 -75 -84 -84 -87 -85 -84 -79 -80 -80
9.8 9.9 9.9 9.9 9.8 9.8 9.8 12 13 12 13 14 14 15 15 15 15 16 16 18 18 18 18 18 18 18 17 17 17 18 18 18 18 18 18 19 19 19 19 19

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?